Recently, China’s National Medical Products Administration (NMPA) approved Enhertu for injection for the treatment of specific types of patients with advanced breast cancer, marking a significant advancement in the global fight against breast cancer. This approval is based on the positive results of the DESTINY-Breast06 clinical trial, signifying a breakthrough for precision targeted therapy in hormone receptor-positive,
On December 25, 2025, NMPA officially approved Enhertu for the treatment of adult breast cancer patients with inoperable or metastatic hormone receptor-positive, HER2-low or ultra-low expression who have progressed after prior endocrine therapy in the metastatic setting. Professor Hu Xichun, Chief Expert of the Department of Internal Medicine at Fudan University Shanghai Cancer Center, stated: “The results of the DESTINY-Breast06 study provide the first evidence that precision targeted therapy can benefit this previously underserved patient population, which is of great scientific significance. With this approval, more HR-positive advanced breast cancer patients with HER2 expression will have the opportunity to benefit from ADC drug therapy.”
The clinical trial data is encouraging: for HR-positive, HER2-low metastatic breast cancer patients who had not received prior chemotherapy, Enhertu reduced the risk of disease progression or death by 38% compared to chemotherapy. More notably, the objective response rate reached 56.5% in HER2-low patients and even as high as 61.8% in the HER2 ultra-low expression population, both significantly higher than in the chemotherapy group.
Beijing South Region Oncology Hospital International Department: Connecting Global Patients with Advanced Treatment
As one of China’s important oncology treatment centers, Beijing South Region Oncology Hospital International Department is dedicated to providing global patients with the most advanced cancer treatment options and personalized medical services. We closely follow international medical progress to ensure patients can access the latest approved treatments promptly.
Our international medical team consists of experienced oncology experts who are not only proficient in the latest treatment technologies but also possess multilingual communication skills, enabling them to provide comprehensive medical support and services to international patients.
Convenient Contact Channels: Multiple Ways for Consultation
We understand the urgent needs of international patients seeking medical assistance, therefore we offer a variety of convenient contact methods:
Phone Consultation: Please call our international patient service hotline at 400-880-3716. Our professional medical coordinators will provide you with detailed consultation and guidance.
WeChat Contact: Add our official WeChat account at 17801183037 to communicate directly with a medical advisor via text, voice, or video.
Email:
- Send inquiries to 100085_010@163.com
- Or contact myimmnet@163.com
Our team will respond to your email within 24 hours, providing you with detailed treatment information, hospital introductions, expert appointments, and other services.
Comprehensive International Patient Services
Beijing South Region Oncology Hospital International Department offers one-stop services for international patients, including:
- Expert consultation and remote consultations
- Treatment plan evaluation and formulation
- Hospitalization arrangements and medical visa support
- Language translation and cultural adaptation assistance
- Guidance on living arrangements during treatment
We deeply understand that each patient’s journey is unique. Therefore, we are committed to providing personalized, humane medical services to ensure you feel professional care and support during your treatment.
Take Action: Obtain Personalized Treatment Advice
If you or your loved ones are facing challenges in breast cancer treatment, especially advanced breast cancer of the HR-positive, HER2-low or ultra-low expression types, now is the time to seek professional medical advice. The approval of Enhertu brings new hope to this patient group.
Contact us immediately through the following methods:
- Call 400-880-3716 to speak directly with a medical advisor
- Add WeChat 17801183037 for instant consultation
- Send an email to 100085_010@163.com or myimmnet@163.com with a detailed description of the condition
Our international medical team will provide professional treatment advice and planning based on your specific situation. At Beijing South Region Oncology Hospital International Department, we believe every patient deserves access to the most advanced and appropriate treatment. We look forward to assisting you on the path to recovery.
Post time: Jan-08-2026